找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Management in Man; Biological Response Paul V. Woolley Book 1989 Kluwer Academic Publishers 1989 Tumor.antibiotics.biology.bone mar

[復(fù)制鏈接]
樓主: STRI
11#
發(fā)表于 2025-3-23 13:45:25 | 只看該作者
12#
發(fā)表于 2025-3-23 14:28:13 | 只看該作者
13#
發(fā)表于 2025-3-23 18:27:06 | 只看該作者
14#
發(fā)表于 2025-3-24 00:42:11 | 只看該作者
15#
發(fā)表于 2025-3-24 05:54:31 | 只看該作者
Current Advances in BMT for Cancer Treatment,, and has recently become an alternative treatment for solid tumors, particularly lymphoma. The purpose of BMT is to repopulate the hemopoietic and lymphoid system following eradication of malignant cells with extremely high doses of chemotherapy (CT) and/or radiotherapy (RT) and, hopefully, to inhi
16#
發(fā)表于 2025-3-24 08:11:08 | 只看該作者
17#
發(fā)表于 2025-3-24 13:19:51 | 只看該作者
The Sphygmochron for Chronobiologic Blood Pressure and Heart Rate Assessment in Cancer Patients, is advocated for everyone, in order to obtain individualized reference standards in health. The assessment of a reliable chronobiologic mean (the .idline-.stimating .tatistic .f .hythm, briefly the MESOR) is particularly pertinent in the case of heart rate for patients with cancer who are treated w
18#
發(fā)表于 2025-3-24 14:50:10 | 只看該作者
https://doi.org/10.1007/3-540-45507-8 patients with cancer are not necessarily well prepared for the translation of biotherapy to the clinic. Biotherapeutic approaches are broad and involve a whole range of physiological responses inherent in cancer biology. The approaches needed to bring these biotherapeutic capabilities to the clinic
19#
發(fā)表于 2025-3-24 21:31:29 | 只看該作者
20#
發(fā)表于 2025-3-25 03:01:47 | 只看該作者
https://doi.org/10.1007/3-540-45507-8e selectively towards a tumour cell rather than towards a normal cell. Selectivity of alkylating agent attack towards tumour cells may also be increased by clinical protection measures on normal tissues (e.g., by autologous bone marrow transplantation). The development of alkylating agent use has th
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 20:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
惠州市| 涟源市| 吴堡县| 永善县| 神池县| 株洲县| 星子县| 巩留县| 海南省| 江源县| 教育| 舒城县| 高台县| 赞皇县| 郸城县| 东乌| 榆树市| 罗定市| 武安市| 芜湖市| 瓮安县| 清苑县| 永泰县| 秭归县| 望谟县| 潞城市| 扶沟县| 綦江县| 类乌齐县| 饶河县| 夏津县| 浦县| 平舆县| 项城市| 衡山县| 余干县| 新密市| 靖安县| 沂水县| 滦平县| 苗栗县|